
Fidaxomicin Use Remains Flat Despite Guideline Change for C difficile Treatment
The study presented at MAD-ID 2025 by Dakota Rorie, PharmD, PGY-2 pharmacotherapy resident at the Medical University of South Carolina (MUSC), examined fidaxomicin prescribing trends over 10 years. The data showed that fidaxomicin use for initial …